"Cancerase" is the world's first new concept of CRISPR anticancer drug, developed by applying gene scissors technology.
The following is our technological advantage over existing anticancer drug technology.
CRISPR/gRNA design to target cancer-specific mutant DNA, applicable to all solid cancers
Precision Breeding with a CRISPR/Cas
Next-generation Genome Editing Technology
Phone:
(765) 807-5525
Location:
Naturegenic Inc. 1281 Win Hentschel Blvd Suite E-1251,
Kurz Purdue Technology Center, West Lafayette, Indiana 47906
Family Site
